NRx Pharmaceuticals (NRXPW) Short Interest Ratio & Short Volume

Short interest is the volume of NRx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 1,500 shares of NRXPW short. Learn More on NRx Pharmaceuticals' current short interest.

NRx Pharmaceuticals saw a decrease in short interest in May. As of May 31st, there was short interest totaling 1,500 shares, a decrease of 16.7% from the previous total of 1,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NRx Pharmaceuticals: Calithera Biosciences, Inc. (0.43%), Cocrystal Pharma, Inc. (0.20%), CytoMed Therapeutics Limited (1.24%), Eloxx Pharmaceuticals, Inc. (0.08%), Galapagos NV (2.95%), MEI Pharma, Inc. (0.04%), NexImmune, Inc. (0.31%), Novo Nordisk A/S (0.75%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling NRXPW is an investing strategy that aims to generate trading profit from NRx Pharmaceuticals as its price is falling. NRXPW shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NRx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NRXPW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRXPW, twice per month. The most recent reporting period available is May, 31 2025.